Women's Health Overview

Principles

Definition

Women's health is a multidisciplinary research field and academic concept that investigates the unique biological, social, environmental, and cultural determinants influencing the health and disease trajectories specific to individuals identifying as women across their lifespan, aiming to understand and address health disparities and improve well-being.

Ontological type

Epidemiology

Health Disparities

Risk Factors

Key developments

Key Figures

Endocrine Foundations of Reproduction era

Harald Löe [1] was a prominent figure in the Endocrine Foundations of Reproduction era, with affiliations at the University of Illinois Urbana-Champaign [3] and the University of Bern [4]. His 1964 paper Periodontal Disease in Pregnancy II. Correlation Between Oral Hygiene and Periodontal Condition [7] illuminated how maternal oral health relates to pregnancy physiology, illustrating early integration of endocrine and systemic factors in women's health. Barry M. Sherman [2] was a pivotal contributor in this era, affiliated with the Albert Einstein College of Medicine [5] and Sorbonne Université [6]. His 1975 paper Hormonal characteristics of the human menstrual cycle throughout reproductive life [8] mapped the constancy and variation of gonadal hormones across the lifespan, providing a framework for fertility, pregnancy, and endometrial health that underpinned subsequent diagnostic and therapeutic approaches.

Cardiometabolic Risk Reframing era

Rebecca D. Jackson [1], affiliated with Harvard University [3] and the University of California, San Francisco [4] in this era, contributed to reframing women's health around cardiometabolic risk. Her key contributions include the Risks and Benefits of Estrogen Plus Progestin in Healthy Postmenopausal Women: Principal Results From the Women's Health Initiative Randomized Controlled Trial [6], which reframed safety and risk in hormone therapy for cardiometabolic outcomes, and Estrogen Plus Progestin and the Incidence of Dementia and Mild Cognitive Impairment in Postmenopausal Women [7], which linked endocrine therapy to cognitive risk, underscoring the need to integrate vascular, metabolic, and neurological health in this era. Marcia L. Stefanick [2], affiliated with Harvard University [3] and Stanford University [5] in this era, contributed to cardiometabolic risk framing through large trials and life-course analyses in postmenopausal women. Her key contributions include the Risks and Benefits of Estrogen Plus Progestin in Healthy Postmenopausal Women [6] and Influence of Estrogen Plus Progestin on Breast Cancer and Mammography in Healthy Postmenopausal Women [8], which together clarified cancer screening and hormone therapy risk implications for this cardiometabolic reframing era.

Hypertensive Pregnancy as Signal era

Catherine Y. Spong [1] is a leading obstetrician and perinatal epidemiologist who was associated with University of California, San Francisco [3] and The University of Texas Southwestern Medical Center [4] in this era. Spong [1] contributed by advancing characterization and management of hypertensive disorders in pregnancy, as detailed in Hypertension in Pregnancy [6], and clarified their relevance to long-term cardiovascular risk. Phyllis August [2] is a physician-scientist affiliated with University of California, San Francisco [3] and Stanford University [5] in this era. August [2]'s work, as described in Hypertension in Pregnancy [6], shaped clinical approaches to hypertensive disorders and supported integration with public-health guidelines to reduce maternal and offspring cardiometabolic burden.